Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Clinical Trial of Intra-arterial Microplasmin Administration in Patients With Acute Intracranial Vertebrobasilar Artery Occlusion

NCT00123266 is registered in ClinicalTrials.gov with ThromboGenics as lead sponsor.

NCT NCT00123266
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00123266 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Clinical Trial of Intra-arterial Microplasmin Administration in Patients With Acute Intracranial Vertebrobasilar Artery Occlusion
Lead sponsor
ThromboGenics
Phase
Phase 2
Overall status
Terminated
Start date
December 31, 2006
Completion date
August 31, 2008
Enrollment
2 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

stroke